Clinical trial
D-dimer to Improve Anticoagulation Management in Adult Patients Supported With Extracorporeal Membrane Oxygenation: a Prospective Cohort Study
NCT03261284 is registered in ClinicalTrials.gov with Wuhan Asia Heart Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- D-dimer to Improve Anticoagulation Management in Adult Patients Supported With Extracorporeal Membrane Oxygenation: a Prospective Cohort Study
- Lead sponsor
- Wuhan Asia Heart Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 1, 2019
- Completion date
- December 30, 2023
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
extracorporeal membrane oxygenation complication, hemorrhage, heparin overdose, thrombosis